This case-control study assesses the association of losing insurance with diabetes outcomes among people with low income served by community health centers.
This economic evaluation examines the descriptive evidence contributing to the shortage of drugs used to treat attention-deficit/hyperactivity disorder in 2022 and 2023.
This Viewpoint discusses US federal budget decisions to eliminate funding for nursing education while recruitment programs continue, leading to an emphasis on addressing immediate needs rather than long-term workforce sustainability.
This JAMA Forum discusses the design of an artificial intelligence (AI) prescription pilot program being deployed in Utah, methods for assessing system performance, and the future of the program.
This cross-sectional study assesses the use of Medicareβs Annual Wellness Visits among older patients with Medicare Advantage and traditional Medicare coverage.
This meta-epidemiological assessment evaluates the reliability of the Global Burden of Disease risk factor estimates for mortality and disability-adjusted life-years.
This cross-sectional study quantifies federal lobbying expenditures by the hospital industry in 2024 and compares variations in lobbying expenditures by hospital ownership status.
This Viewpoint discusses the Make America Healthy Again Commissionβs βMake Our Children Healthy Againβ report, which implicates the food industry for its role in the chronic disease epidemic.
This JAMA Forum discusses changes under the Trump administration to the vaccination schedule, oversight of vaccine safety, the National Vaccine Injury Compensation Program, and the Vaccines for Children program.
This cross-sectional study examines if intersectionality based on race and low-income status is related to food insecurity rates and the role that the Supplemental Nutrition Assistance Program plays.
This cross-sectional study examines the association between state laws that prohibit prior authorization for buprenorphine and treatment retention among privately insured patients.
This Viewpoint discusses current regulatory frameworks governing the use of generative artificial intelligence (AI) in health care and proposes an alternative oversight system.
This JAMA Forum discusses health coverage implications for Affordable Care Act Marketplace plans and Medicaid after passage of the budget reconciliation package in 2025 and changes in the rates of uninsurance.